InsidersTradesSigma
Follow the APOGEE THERAPEUTICS INC share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €10.2bn. The latest transaction was reported on 1 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: CARL DAMBKOWSKI. The full history is free.
Analysts rate APOGEE THERAPEUTICS INC Hold (neutral), based on 11 analysts. Average price target: US$134.85.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
APOGEE THERAPEUTICS INC es una empresa centrada en el desarrollo de tratamientos terapéuticos innovadores. Cotiza en NASDAQ bajo el ticker XNAS.